Provention Bio Inc buy Chardan Capital
Start price
13.03.23
/
50%
€22.41
Target price
13.03.24
€23.30
Performance (%)
1.07%
End price
14.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by Chardan_Capital shows slight gains of 1.07%. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Provention Bio Inc | - | - | - |
| iShares Core DAX® | -1.338% | -5.619% | 3.378% |
| iShares Nasdaq 100 | -1.067% | 2.598% | 19.132% |
| iShares Nikkei 225® | -1.991% | -6.512% | 27.854% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% |
Comments by Chardan_Capital for this prediction
In the thread Provention Bio Inc diskutieren
Provention Bio, Inc. (NASDAQ: PRVB) had its price target lowered by analysts at Chardan Capital from $30.00 to $25.00. They now have a "buy" rating on the stock.
Ratings data for PRVB provided by MarketBeat
In the thread Trading Provention Bio Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten